AMOXICILLIN AND CLAVULANATE POTASSIUM
AMOXICILLIN; CLAVULANATE POTASSIUM
Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 065205 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET, CHEWABLE;ORAL - 400MG;EQ 57MG BASE Sponsor TEVA Submission history Latest submission status date: 2024-05-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 065205 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET, CHEWABLE;ORAL - 400MG;EQ 57MG BASE Sponsor TEVA Submission history Latest submission status date: 2024-05-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.